Neogen Corporation

NEOG Healthcare Medical Devices

Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.

Revenue
+6.50%
EPS
−129.4%
Free cash flow
+135.6%
Total debt
−2.31%

Quarter to August 2026, against a year earlier

11.72 0.04 +0.34%
Market cap
$2.6B
P/E
0.0×
Fwd P/E
−93.3×
Dividend yield
—
F-score
5/9
Altman Z
1.11
Beneish M
−2.43
Dividend safety
n/a
Older periods Nov '25 Feb '26 May '26 Aug '26
Piotroski F-Score

+8 more TTM periods

4 4 5 6
ROE
(25.25%) (25.57%) (0.38%) (2.67%)
ROA
(16.26%) (16.47%) (0.23%) (1.68%)
ROIC
(14.24%) (14.53%) (0.50%) (0.17%)
Return on Tangible Assets
(79.32%) (78.94%) (1.02%) (7.35%)
Average Days of Receivables
54.73 57.48 61.56 56.24
Free Cash Flow per Share
(0.08) 0.03 0.15 0.23
Free Cash Flow
(17.87) 6.30 32.00 49.90
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026